Literature DB >> 30214589

miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-κB1 in human ovarian cancer cells.

Xiaoxiao Liu1, Baofeng Yao2, Zhiming Wu3.   

Abstract

The aberrant expression of microRNA (miRNA)-199a-5p has been frequently reported in a number of cancer types, but to the best of our knowledge, this has not been reported in ovarian cancer (OC). The role and the molecular mechanism of miR-199a-5p in OC have not been reported. Therefore, the present study investigated the effects of miR-199a-5p overexpression on the proliferation and invasion of OC cells. The level of miR-199a-5p in OC cell lines was determined by reverse transcription-quantitative polymerase chain reaction. The miR-199a-5p mimic was transiently transfected into OC cells using Lipofectamine™ 2000 reagent. Subsequently, the BrdU-ELISA results indicated that the exogenous expression of miR-199a-5p inhibited cell proliferation. In addition, miR-199a-5p overexpression was able to inhibit the invasion of HO-8910 and ES-2 cells. RT-qPCR was performed to determine the expression of matrix metalloproteinase (MMP)-2 and -9 in OC cells. NF-κB1 expression was reduced by upregulation of miR-199a-5p. Bioinformatics analysis predicted that NF-κB1 was a potential target of miR-199a-5p. Luciferase reporter assay further confirmed that miR-199a-5p was able to directly target the 3'UTR of NF-κB1. In conclusion, miRNA-199a-5p may suppress the proliferation and invasion of human ovarian cancer cells by directly targeting NF-κB1.

Entities:  

Keywords:  invasion; microRNA-199a-5p; ovarian cancer; proliferation

Year:  2018        PMID: 30214589      PMCID: PMC6126267          DOI: 10.3892/ol.2018.9170

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  54 in total

1.  Mutations in MicroRNA Genes and Their Binding Sites are Infrequently Associated with Human Colorectal Cancer in the Kashmiri Population.

Authors:  Raihana Maqbool; Rehana Ismail; Mahboob- Ul- Hussain
Journal:  Microrna       Date:  2014

2.  Differential roles of miR-199a-5p in radiation-induced autophagy in breast cancer cells.

Authors:  Heqing Yi; Bing Liang; Jie Jia; Nan Liang; Huiying Xu; Guizhi Ju; Shumei Ma; Xiaodong Liu
Journal:  FEBS Lett       Date:  2013-01-18       Impact factor: 4.124

3.  Keloid microRNA expression analysis and the influence of miR-199a-5p on the proliferation of keloid fibroblasts.

Authors:  Z-Y Wu; L Lu; J Liang; X-R Guo; P H Zhang; S-J Luo
Journal:  Genet Mol Res       Date:  2014-04-14

4.  miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression.

Authors:  Hai-Shuang Lin; Jia-Nan Gong; Rui Su; Ming-Tai Chen; Li Song; Chao Shen; Fang Wang; Yan-Ni Ma; Hua-Lu Zhao; Jia Yu; Wei-Wei Li; Li-Xia Huang; Xin-Hua Xu; Jun-Wu Zhang
Journal:  J Leukoc Biol       Date:  2014-09-25       Impact factor: 4.962

5.  miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.

Authors:  Ping Chen; Colles Price; Zejuan Li; Yuanyuan Li; Donglin Cao; Anissa Wiley; Chunjiang He; Sandeep Gurbuxani; Rejani B Kunjamma; Hao Huang; Xi Jiang; Stephen Arnovitz; Mengyi Xu; Gia-Ming Hong; Abdel G Elkahloun; Mary Beth Neilly; Mark Wunderlich; Richard A Larson; Michelle M Le Beau; James C Mulloy; Paul P Liu; Janet D Rowley; Jianjun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

6.  miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells.

Authors:  Zhongxue Ye; Le Zhao; Jie Li; Wei Chen; Xu Li
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

7.  The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.

Authors:  Toshihiko Itesako; Naohiko Seki; Hirofumi Yoshino; Takeshi Chiyomaru; Takeshi Yamasaki; Hideo Hidaka; Tomokazu Yonezawa; Nijiro Nohata; Takashi Kinoshita; Masayuki Nakagawa; Hideki Enokida
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

8.  Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.

Authors:  Stefano Sestini; Mattia Boeri; Alfonso Marchiano; Giuseppe Pelosi; Carlotta Galeone; Carla Verri; Paola Suatoni; Nicola Sverzellati; Carlo La Vecchia; Gabriella Sozzi; Ugo Pastorino
Journal:  Oncotarget       Date:  2015-10-20

Review 9.  Clinical Potential of microRNA-7 in Cancer.

Authors:  Jessica L Horsham; Felicity C Kalinowski; Michael R Epis; Clarissa Ganda; Rikki A M Brown; Peter J Leedman
Journal:  J Clin Med       Date:  2015-08-25       Impact factor: 4.241

10.  MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.

Authors:  Xiaolong Wang; Yaming Li; Wenwen Qi; Ning Zhang; Mingjuan Sun; Qiang Huo; Chang Cai; Shangge Lv; Qifeng Yang
Journal:  Oncotarget       Date:  2015-10-20
View more
  11 in total

1.  The downregulation of miR-519a predicts poor prognosis and contributes to tumor progression in gastric cancer.

Authors:  Huimei Cai; Hui Lin; Wenyu Cao; Juan Sun; Yudian Huang; Yuehua Fang
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

2.  Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma.

Authors:  Lu Zhang; Hongxin Cao; Guanghui Gu; Dehui Hou; Yunhao You; Xiang Li; Yunzhen Chen; Guangjun Jiao
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

3.  Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue.

Authors:  Yahui Jiang; Yiwen Shi; Tianjiao Lyu; Hua Liu; Lifei Shen; Tianyu Zhou; Weiwei Feng
Journal:  Cancer Manag Res       Date:  2021-08-21       Impact factor: 3.989

4.  CircFoxo3 Promotes Adriamycin Resistance Through Regulation of miR-199a-5p/ATP Binding Cassette Subfamily C Member 1 Axis in Hepatocellular Carcinoma.

Authors:  Wei Huang; Feizhou Huang; Chao Feng
Journal:  Onco Targets Ther       Date:  2020-06-08       Impact factor: 4.147

5.  LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.

Authors:  Qian Hua; Mingming Jin; Baoming Mi; Fei Xu; Tian Li; Li Zhao; Jianjun Liu; Gang Huang
Journal:  J Hematol Oncol       Date:  2019-09-05       Impact factor: 17.388

6.  The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI.

Authors:  Maria Carmen Asensio-Lopez; Yassine Sassi; Fernando Soler; Maria Josefa Fernandez Del Palacio; Domingo Pascual-Figal; Antonio Lax
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

7.  Curcumin derivative ST09 modulates the miR-199a-5p/DDR1 axis and regulates proliferation and migration in ovarian cancer cells.

Authors:  Febina Ravindran; Jinsha Koroth; Meghana Manjunath; Suchitra Narayan; Bibha Choudhary
Journal:  Sci Rep       Date:  2021-11-26       Impact factor: 4.379

Review 8.  Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver.

Authors:  Anuradha Pandit; Yasmin Begum; Priyanka Saha; Amit Kumar Srivastava; Snehasikta Swarnakar
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

Review 9.  Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer.

Authors:  Arkadiusz Gajek; Patrycja Gralewska; Agnieszka Marczak; Aneta Rogalska
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

10.  LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.

Authors:  Bin Yang; Lin Jia; Hui Ren; Caibao Jin; Qingrong Ren; Haiyuan Zhang; Desheng Hu; Hao Zhang; Liu Hu; Tao Xie
Journal:  Mol Genet Genomic Med       Date:  2019-11-29       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.